Effect of etidronate treatment on bone mass of male nephrolithiasis patients with idiopathic hypercalciuria and osteopenia

Effect of etidronate treatment on bone mass of male nephrolithiasis patients with idiopathic hypercalciuria and osteopenia

Autor Heilberg, I. P. Google Scholar
Martini, L. A. Google Scholar
Teixeira, S. H. Google Scholar
Szejnfeld, V. L. Google Scholar
Carvalho, A. B. Google Scholar
Lobao, R. Google Scholar
Draibe, S. A. Google Scholar
Instituição Universidade Federal de São Paulo (UNIFESP)
Resumo Osteopenia is frequently found among calcium stone forming (CSF) patients with hypercalciuria. We investigated the effect of a 2-year therapeutic course of etidronate, a bone-sparing agent, in 7 young male CSF patients. the treatment consisted of a cyclic intermittent administration of phosphate followed by sodium etidronate and calcium supplementation every 74 days. Bone mineral density (BMD) measured at 12-month intervals and bone biopsies performed at baseline and after 2 years were the primary efficacy parameters. Mean lumbar spine BMD increased significantly after the 1st year by 2.6 +/- 1.0% (mean +/- SE, p < 0.05) and nonsignificantly after the 2nd year by 5.6 +/- 2.6 %. Nonsignificant changes were observed for femoral neck mean BMD after either the 1st or the 2nd year (decrease of 2.0 +/- 1.0% and 2.0 +/- 3.0%, respectively). Mean histomorphometric parameters showed that bone volume, osteoid volume, and eroded surfaces did not differ from baseline (13.9 +/- 2.2 vs. 12.2 +/- 1.1%, 1.2 +/- 0.7 vs. 2.6 +/- 0.7%, and 20.7 +/- 6.2 vs. 13.7 +/- 1.3%, respectively). Osteoid surface was significantly lower than baseline values (9.5 +/- 5.2 vs. 18.8 +/- 5.3%, p < 0.05). These data suggest that etidronate given to young male CSF patients presenting with hypercalciuria and osteopenia led to a significant amelioration of BMD, evident only in the lumbar spine after 1 year of treatment. There was no histological evidence of long-term improvement in bone remodeling.
Palavra-chave bisphosphonate
urinary calcium
Idioma Inglês
Data de publicação 1998-08-01
Publicado em Nephron. Basel: Karger, v. 79, n. 4, p. 430-437, 1998.
ISSN 0028-2766 (Sherpa/Romeo, fator de impacto)
Publicador Karger
Extensão 430-437
Fonte http://dx.doi.org/10.1159/000045089
Direito de acesso Acesso restrito
Tipo Artigo
Web of Science WOS:000075230300007
Endereço permanente http://repositorio.unifesp.br/handle/11600/25937

Exibir registro completo


Arquivo Tamanho Formato Visualização

Não existem arquivos associados a este item.

Este item está nas seguintes coleções



Minha conta